Scientists develop a cheaper method that might help create fuels from plants

January 08, 2021

COLUMBUS, Ohio - Scientists have figured out a cheaper, more efficient way to conduct a chemical reaction at the heart of many biological processes, which may lead to better ways to create biofuels from plants.

Scientists around the world have been trying for years to create biofuels and other bioproducts more cheaply; this study, published today in the journal Scientific Reports, suggests that it is possible to do so.

"The process of converting sugar to alcohol has to be very efficient if you want to have the end product be competitive with fossil fuels," said Venkat Gopalan, a senior author on the paper and professor of chemistry and biochemistry at The Ohio State University. "The process of how to do that is well-established, but the cost makes it not competitive, even with significant government subsidies. This new development is likely to help lower the cost."

At the heart of their discovery: A less expensive and simpler method to create the "helper molecules" that allow carbon in cells to be turned into energy. Those helper molecules (which chemists call cofactors) are nicotinamide adenine dinucleotide (NADH) and its derivative (NADPH). These cofactors in their reduced forms have long been known to be a key part of turning sugar from plants into butanol or ethanol for fuels. Both cofactors also play an important role in slowing the metabolism of cancer cells and have been a target of treatment for some cancers.

But NADH and NADPH are expensive.

"If you can cut the production cost in half, that would make biofuels a very attractive additive to make flex fuels with gasoline," said Vish Subramaniam, a senior author on the paper and recently retired professor of engineering at Ohio State. "Butanol is often not used as an additive because it's not cheap. But if you could make it cheaply, suddenly the calculus would change. You could cut the cost of butanol in half, because the cost is tied up in the use of this cofactor."

To create these reduced cofactors in the lab, the researchers built an electrode by layering nickel and copper, two inexpensive elements. That electrode allowed them to recreate NADH and NADPH from their corresponding oxidized forms. In the lab, the researchers were able to use NADPH as a cofactor in producing an alcohol from another molecule, a test they did intentionally to show that ¬the electrode they built could help convert biomass - plant cells - to biofuels. This work was performed by Jonathan Kadowaki and Travis Jones, two mechanical and aerospace engineering graduate students in the Subramaniam lab, and Anindita Sengupta, a postdoctoral researcher in the Gopalan lab.

But because NADH and NADPH are at the heart of so many energy conversion processes inside cells, this discovery could aid other synthetic applications.

Subramaniam's previous work showed that electromagnetic fields can slow the spread of some breast cancers. He retired from Ohio State on Dec. 31.

This finding is connected, he said: It might be possible for scientists to more easily and affordably control the flow of electrons in some cancer cells, potentially slowing their growth and ability to metastasize.

Subramaniam also has spent much of his later scientific career exploring if scientists could create a synthetic plant, something that would use the energy of the sun to convert carbon dioxide into oxygen. On a large enough scale, he thought, such a creation could potentially reduce the amount of carbon dioxide in the atmosphere and help address climate change.

"I've always been interested in that question of, 'Can we make a synthetic plant? Can we make something that can solve this global warming problem with carbon dioxide?'" Subramaniam said. "If it's impractical to do it with plants because we keep destroying them via deforestation, are there other inorganic ways of doing this?"

This discovery could be a step toward that goal: Plants use NADPH to turn carbon dioxide into sugars, which eventually become oxygen through photosynthesis. Making NADPH more accessible and more affordable could make it possible to produce an artificial photosynthesis reaction.

But its most likely and most immediate application is for biofuels.

That the researchers came together for this scientific inquiry was rare: Biochemists and engineers don't often conduct joint laboratory research.

Gopalan and Subramaniam met at a brainstorming session hosted by Ohio State's Center for Applied Plant Sciences (CAPS), where they were told to think about "big sky ideas" that might help solve some of society's biggest problems. Subramaniam told Gopalan about his work with electrodes and cells, "and the next thing we knew, we were discussing this project," Gopalan said. "We certainly would not have talked to each other if it were not for the CAPS workshop."
-end-
CONTACT: Venkat Gopalan, gopalan.5@osu.edu

Written by Laura Arenschield, arenschield.2@osu.edu

Ohio State University

Related Cancer Cells Articles from Brightsurf:

Cancer researchers train white blood cells to attacks tumor cells
Scientists at the National Center for Tumor Diseases Dresden (NCT/UCC) and Dresden University Medicine, together with an international team of researchers, were able to demonstrate that certain white blood cells, so-called neutrophil granulocytes, can potentially - after completing a special training program -- be utilized for the treatment of tumors.

New way to target some rapidly dividing cancer cells, leaving healthy cells unharmed
Scientists at Johns Hopkins Medicine and the University of Oxford say they have found a new way to kill some multiplying human breast cancer cells by selectively attacking the core of their cell division machinery.

Breast cancer cells use message-carrying vesicles to send oncogenic stimuli to normal cells
According to a Wistar study, breast cancer cells starved for oxygen send out messages that induce oncogenic changes in surrounding normal epithelial cells.

Breast cancer cells turn killer immune cells into allies
Researchers at Johns Hopkins University School of Medicine have discovered that breast cancer cells can alter the function of immune cells known as Natural killer (NK) cells so that instead of killing the cancer cells, they facilitate their spread to other parts of the body.

Breast cancer cells can reprogram immune cells to assist in metastasis
Johns Hopkins Kimmel Cancer Center investigators report they have uncovered a new mechanism by which invasive breast cancer cells evade the immune system to metastasize, or spread, to other areas of the body.

Engineered immune cells recognize, attack human and mouse solid-tumor cancer cells
CAR-T therapy has been used successfully in patients with blood cancers such as lymphoma and leukemia.

Drug that keeps surface receptors on cancer cells makes them more visible to immune cells
A drug that is already clinically available for the treatment of nausea and psychosis, called prochlorperazine (PCZ), inhibits the internalization of receptors on the surface of tumor cells, thereby increasing the ability of anticancer antibodies to bind to the receptors and mount more effective immune responses.

Engineered bone marrow cells slow growth of prostate and pancreatic cancer cells
In experiments with mice, researchers at the Johns Hopkins Kimmel Cancer Center say they have slowed the growth of transplanted human prostate and pancreatic cancer cells by introducing bone marrow cells with a specific gene deletion to induce a novel immune response.

First phase i clinical trial of CRISPR-edited cells for cancer shows cells safe and durable
Following the first US test of CRISPR gene editing in patients with advanced cancer, researchers report these patients experienced no negative side effects and that the engineered T cells persisted in their bodies -- for months.

Zika virus' key into brain cells ID'd, leveraged to block infection and kill cancer cells
Two different UC San Diego research teams identified the same molecule -- αvβ5 integrin -- as Zika virus' key to brain cell entry.

Read More: Cancer Cells News and Cancer Cells Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.